Sigyn Therapeutics, Inc. (SIGY)

Market Cap	7.41M
Revenue (ttm)	n/a
Net Income (ttm)	-4.96M
Shares Out	1.29M
EPS (ttm)	-1.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	256
Open	5.75
Previous Close	5.50
Day's Range	5.75 - 5.75
52-Week Range	0.15 - 12.80
Beta	-1.04
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SIGY

Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, inclu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: SIGY